Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Cappellini, A.
1473  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

METhodological RadiomICs Score (METRICS): A quality scoring..:

Kocak, B ; Akinci d'Antonoli, T ; Mercaldo, N...
hal-04305543.  , 2023
Link: https://hal.science/hal-..
 
?
2

Design and In-orbit Demonstration of REGULUS, an Iodine ele..:

Bellomo N ; Magarotto M ; Manente M...
info:eu-repo/semantics/altIdentifier/wos/WOS:000658572200001.  , 2022
Link: https://hdl.handle.net/1..
 
?
3

Design and In-orbit Demonstration of REGULUS, an Iodine ele..:

Bellomo N ; Magarotto M ; Manente M...
info:eu-repo/semantics/altIdentifier/wos/WOS:000658572200001.  , 2022
Link: http://hdl.handle.net/11..
 
?
4

Lamin B1 accumulation's effects on autosomal dominant leuko..:

Ratti S ; Rusciano I ; Mongiorgi S...
info:eu-repo/semantics/altIdentifier/pmid/34685544.  , 2021
Link: http://hdl.handle.net/11..
 
?
5

Clinical and molecular insights in erythropoiesis regulatio..:

Parisi S ; Finelli C ; Fazio A...
info:eu-repo/semantics/altIdentifier/pmid/33467674.  , 2021
Link: https://hdl.handle.net/1..
 
?
6

The Combination of AHCC and ETAS Decreases Migration of Col..:

Paganelli F ; Chiarini F ; Palmieri A...
info:eu-repo/semantics/altIdentifier/pmid/34959725.  , 2021
Link: http://hdl.handle.net/11..
 
?
7

Cell signaling pathways in autosomal-dominant leukodystroph..:

Ratti S ; Rusciano I ; Mongiorgi S...
info:eu-repo/semantics/altIdentifier/pmid/33034697.  , 2021
Link: https://hdl.handle.net/1..
 
?
8

Lamin A and Prelamin A Counteract Migration of Osteosarcoma..:

Evangelisti C ; Paganelli F ; Giuntini G...
info:eu-repo/semantics/altIdentifier/pmid/32235738.  , 2020
Link: http://hdl.handle.net/11..
 
?
9

Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinas..:

Cappellini, A ; Mongiorgi, S ; Finelli, C...
doi:10.1096/fj.202000933rr.  , 2020
Link: https://doi.org/10.1096/..
 
?
10

Appropriateness of prescription of oral anticoagulant thera..:

Antoniazzi S ; Ardoino I ; Proietti M...
info:eu-repo/semantics/altIdentifier/pmid/31218738.  , 2019
Link: http://hdl.handle.net/11..
 
?
11

Therapeutic targeting of CK2 in acute and chronic leukemias:

Buontempo, F ; McCubrey, J A ; Orsini, E...
info:eu-repo/semantics/altIdentifier/pmid/28951560.  , 2018
Link: http://hdl.handle.net/11..
 
?
12

Appropriateness of oral anticoagulant therapy prescription ..:

C. Franchi ; S. Antoniazzi ; M. Proietti...
info:eu-repo/semantics/altIdentifier/pmid/29745441.  , 2018
Link: http://hdl.handle.net/24..
 
?
13

Appropriateness of oral anticoagulant therapy prescription ..:

Franchi C ; Antoniazzi S ; Proietti M...
info:eu-repo/semantics/altIdentifier/pmid/29745441.  , 2018
Link: http://hdl.handle.net/11..
 
?
14

Therapeutic targeting of CK2 in acute and chronic leukemias:

Buontempo, F ; McCubrey, J A ; Orsini, E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770594/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
15

Therapeutic targeting of CK2 in acute and chronic leukemias:

Buontempo, F ; McCubrey, J A ; Orsini, E...
info:eu-repo/semantics/altIdentifier/pmid/28951560.  , 2018
Link: http://hdl.handle.net/11..
 
1-15